Recent advances in developing targeted protein degraders

被引：0

作者：

Cheng, Binbin ^{[1
,2
]}

Li, Hongqiao ^{[3
]}

Peng, Xiaopeng ^{[4
]}

Chen, Jianjun ^{[5
]}

Shao, Chuxiao ^{[2
]}

Kong, Zhihua ^{[6
]}

机构：

[1] Hubei Polytech Univ, Hubei Key Lab Kidney Dis Pathogenesis & Intervent, Huangshi 435003, Peoples R China

[2] Wenzhou Med Univ, Lishui Peoples Hosp, Cent Lab, Lishui Hosp, Lishui 323000, Zhejiang, Peoples R China

[3] Cent Hosp Huangshi, Huangshi 435000, Peoples R China

[4] Gannan Med Univ, Coll Pharm, Ganzhou 314000, Peoples R China

[5] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, NMPA Key Lab Res & Evaluat Drug Metab, Guangzhou 510515, Peoples R China

[6] Guangdong Prov Hosp, Integrated Tradit Chinese & Western Med, Foshan 528200, Peoples R China

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2025年 / 284卷

基金：

中国国家自然科学基金;

关键词：

Targeted protein degradation; Small molecule ligands; PROTACs; Molecular glues; LYTACs; HyTTD; ANTIBODY-BASED PROTACS; MDM2; INHIBITORS; CANCER-THERAPY; DEGRADATION; DISCOVERY; LIGASE; ASGPR; POTENT;

D O I：

10.1016/j.ejmech.2024.117212

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Targeted protein degradation (TPD) represents a promising therapeutic approach, encompassing several innovative strategies, including but not limited to proteolysis targeting chimeras (PROTACs), molecular glues, hydrophobic tag tethering degraders (HyTTD), and lysosome-targeted chimeras (LYTACs). Central to TPD are small molecule ligands, which play a critical role in mediating the degradation of target proteins. This review summarizes the current landscape of small molecule ligands for TPD molecules. These small molecule ligands can utilize the proteasome, lysosome, autophagy, or hydrophobic-tagging system to achieve the degradation of target proteins. The article mainly focuses on introducing their design principles, application advantages, and potential limitations. A brief discussion on the development prospects and future directions of TPD technology was also provided.

引用

页数：19

共 50 条

[21] Innovative Protein Degraders for Targeted Cancer and Viral Therapy
Kargbo, Robert B.
ACS MEDICINAL CHEMISTRY LETTERS, 2025, 16 (02): : 222 - 223
[22] Targeted protein knockdown using small molecule degraders
Raina, Kanak
Crews, Craig M.
CURRENT OPINION IN CHEMICAL BIOLOGY, 2017, 39 : 46 - 53
[23] Recent advances in developing molecular tools for targeted genome engineering of mammalian cells
Lim, Kwang-il
BMB REPORTS, 2015, 48 (01) : 6 - 12
[24] Recent Advances in Smart Linkage Strategies for Developing Drug Conjugates for Targeted Delivery
Jie Zhang
Zeyu Yang
Yu Liu
Yuying Liu
Jingkun Qu
Xiaoyan Pan
Topics in Current Chemistry, 383 (2)
[25] Fundamental aspects of DMPK optimization of targeted protein degraders
Cantrill, Carina
Chaturvedi, Prasoon
Rynn, Caroline
Schaffland, Jeannine Petrig
Walter, Isabelle
Wittwer, Matthias B.
DRUG DISCOVERY TODAY, 2020, 25 (06) : 969 - 982
[26] Macrocyclic peptides as a new class of targeted protein degraders
Jing, Xuefei
Mackay, Joel P.
Passioura, Toby
RSC CHEMICAL BIOLOGY, 2025, 6 (03): : 326 - 337
[27] Targeted protein degradation in drug development: Recent advances and future challenges
Song, Jian
Hu, Mingzheng
Zhou, Jun
Xie, Songbo
Li, Tianliang
Li, Yan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 261
[28] Targeted protein degraders march towards the clinic for neurodegenerative diseases
Hassan, Md. Imtaiyaz
Kumar, Dhiraj
AGEING RESEARCH REVIEWS, 2022, 78
[29] PROTAC™ targeted protein degraders: Exciting modality for drug discovery
Araujo, Erika
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
[30] Design and optimization of targeted protein degraders: Leveraging computational tools
Che, Ye
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258

← 1 2 3 4 5 →